We just launched 5 new Congress Trading strategies

Launching 5 New Congress Trading Strategies

Last year, we launched strategies tracking the individual trades of 4 members of Congress: Tommy Tuberville, Nancy Pelosi, Shelley Moore Capito, and Tom Carper. The goal was to track these politicians’ trading performance, and make it easier for anyone to copytrade with their own portfolios.

Those first four strategies were just the tip of the iceberg, as there are dozens of actively trading members of Congress who we think are worth paying attention to.

We are now excited to launch 5 new strategies, tracking other Congressional traders who have shown a strong track record of beating the market. We also improved our methodology, to incorporate data from annual filings in addition to the individual trade filings.

Three of our individual Congress strategies - the Nancy Pelosi strategy, Josh Gottheimer Strategy, and Dan Meuser Strategy - are now available for automated copytrading through our partnership with Quantbase.

You can start copytrading by visiting www.quiverquant.com/quantbase, or check out our new tutorial on getting set-up with Quantbase.

The Josh Gottheimer Strategy

Rep. Josh Gottheimer (D-NJ) has consistently been both one of the most active and the most successful traders in Congress. In 2023, he disclosed over $50m worth of trading, with 234 different purchases and 302.

His strategy has shown nearly a 25% CAGR since 2019, beating the market by a wide margin.

While Gottheimer trades across a wide variety of sectors, some of his most interesting trades has been in defense stocks, such as his purchase of Northrop Grumman stock in September (shortly before they had a 15% rally). Gottheimer sits on the House Select Committee on Intelligence, which gives him access to confidential information that could be particularly relevant for defense companies.

Gottheimer has claimed that his investments are managed by a third party, and he is not directly involved with their trading. However, he has not placed his money in a qualified blind trust, and his strong historical performance seems to indicate that his trades could still be worth tracking.

The Dan Meuser Strategy

Although he is not an incredibly active trader, Rep. Daniel Meuser (R-PA) has had an impressive track record of well-timed trades, and his backtested strategy has had a CAGR of 32% since 2019 (higher than any of the individual Congressmember strategies that we’ve launched so far).

He has been a long-time holder of Nvidia, which has returned over 1,000% since he first opened his position. He has also had smaller positions in other high-performing big tech stocks, such as Google, Microsoft, and Apple.

Meuser currently sits on the Committee on Financial Services, as well as the Committee on Small Business.

The Tina Smith Strategy

While Senator Tina Smith (D-MN) had historically not shown strong outperformance, she has had a recent run of incredibly suspicious and well-timed trades (which we covered in our last newsletter).

Off the back of recent trades in $AORT and $TCMD, the Tina Smith strategy has returned 35% since October 18th, beating the market significantly.

However, over the full backtest (since 2019) the strategy has had a much more modest 12% CAGR. But with her recent performance, it might be worth keeping an eye on this strategy going forward.

The Donald Beyer Strategy

Rep. Donald Beyer (D-VA) has not actively traded in several months, but made a flurry of trades in 2021 and 2022 that helped his strategy to a 19.75% CAGR over the backtest period.

If he gets back into the habit of actively trading in the future, we will be keeping a close eye on his holdings, and see if he’s able to replicate his past success.

The Sheldon Whitehouse Strategy

Our strategy tracking Senator Sheldon Whitehouse (D-RI) has shown a 16% backtested CAGR since 2014, bolstered by his frequent trading in companies that are closely tied to his committee memberships.

Recently, while sitting on the Senate finance subcommittee for healthcare, Whitehouse disclosed purchases in several healthcare companies (including Kenvue, Novartis, and Eli Lilly).

Earlier this month, he disclosed selling shares of an environmental solutions company called Veralto, while sitting on the Senate committee on environment.

Like Meuser, several of Whitehouse’s largest current holdings are big tech companies, with holdings in NVDA, GOOGL, AMZN, and MSFT. However, his strategy also currently holds companies with more links to his committee memberships, such as United Healthcare (UNH) and Lam Research Corp (LRCX).

Conclusion

Here’s a summary of how each of our individual Congressmember strategies have performed over the last year:

As we continue to grow Quiver Strategies, and roll out new strategies based on our data, we would love to hear your input on where to look next. Please reach out to [email protected] if you have any suggestions on new strategies to look into, or other datasets that we should be tracking

You can follow us on Twitter for more insights from Congressional Trading data, and updates on the push towards better regulation and transparency.